Echocardiograms of 143 patients with isolated systolic hypertension were compared to 808 patients with combined (systolic and diastolic) hypertension. All patients met electrocardiographic criteria for left ventricular hypertrophy and were evaluated off medication. Patients with isolated systolic hypertension were older, shorter, weighed less, and were mostly women, but body mass index (BMI) was similar in both groups. Systolic blood pressure (SBP) was 172 mm Hg in isolated systolic hypertension, 174 mm Hg in combined (P ϭ not significant). Diastolic blood pressure was 83 and 101 mm Hg, respectively (P Ͻ .001). Despite having mean arterial pressure 12 mm Hg lower than patients with combined hypertension, the group with isolated systolic hypertension had equally severe abnormalities of left ventricular mass, left ventricular geometric patterns, and measures of systolic and diastolic function. Peripheral resistance was lower and pulse pressure/stroke volume ratio (arterial stiffness index) was higher and the isovolumic relaxation time shorter in isolated systolic hypertension. Multiple regression analyses identified age, height, BMI, stress-corrected mid wall shortening, stroke volume, male gender, and systolic or mean blood pressure (but not isolated systolic hypertension) as independent correlates of left ventricular mass. Relative wall thickness was independently associated with isolated systolic hypertension (P ϭ .001) in addition to mean pressure and other covariates. The present results add support to the concept that systolic blood pressure (SBP) is a stronger determinant than diastolic pressure of cardiac target organ damage in hypertension.
levated systolic blood pressure (SBP) either isolated or combined with elevated diastolic (DBP), has long been recognized as a strong contributor to the development of target organ disease and cardiovascular complications. [1] [2] [3] [4] [5] [6] In the Framingham Study 1 men of all ages with isolated systolic hypertension (ISH) had substantially higher incidences of coronary heart disease, stroke, heart failure, and peripheral arterial disease than men with isolated diastolic hypertension. Combined systolic and diastolic hypertension (CSDH) carried only marginally higher risk than ISH. Data from the Multiple Risk Factor Intervention Trial, of 361,662 middle-aged men with follow-up of up to 12 years, showed a strong, continuous, and graded relationship between systolic BP and incidence of coronary events, strokes, and cardiovascular deaths. 2 The importance of elevated SBP has been further underlined by large interventional trials in patients with ISH, which demonstrated substantial reductions in the incidence of strokes 7, 8 and coronary events. 7 Numerous studies have shown that left ventricular (LV) hypertrophy is a strong and independent predictor of cardiovascular events.
9 - 13 The risk of fatal and nonfatal events is two to four times higher in those patients with, as opposed to those without LV hypertrophy and is especially high in those with concentric LV pattern. 13, 14 Although numerous studies demonstrate a strong relationship of SBP and structural changes in the LV, most data were derived from populations with primarily diastolic (with or without systolic) hypertension. Few studies examined changes in LV structure in patients with ISH, [15] [16] [17] [18] but, in general, comparison to patients with diastolic hypertension were not made and neither LV geometric patterns nor measures of LV function were examined. One study 18 found a high prevalence of concentric remodeling in elderly patients with ISH selected from a population survey and a recent brief report from a study of the Systolic Hypertension in the Elderly Program showed a 13% reduction in LV mass index in patients with ISH treated with chlorothalidone over a 3-year period. 19 Both of these studies, 18, 19 , however, included patients with fairly low average LV mass.
The purpose of the present study, was to assess LV structural and functional changes in patients with ISH and evidence of electrocardiographic LV hypertrophy and compare them to similar patients with CSDH, recruited from the same population.
Methods

Study Population
Subjects of the present study are patients participating in the echocardiographic study of the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) trial. LIFE is an ongoing randomized triple-blind multicenter trial carried out in more than 900 centers in Denmark, Finland, Iceland, Norway, Sweden, the United Kingdom, and the United States. Design characteristics, inclusion and exclusion criteria have been previously published. 20 In brief, women and men between the age of 55 and 80 years with mean seated SBP of 160 to 200 mm Hg or diastolic 95 to 115 mm Hg and evidence of electrocardiographic LV hypertrophy (see below) were recruited into the study. Two sets of criteria were used to determine presence of LV hypertrophy: 1) the product of QRS duration times the Cornell voltage combination (RaVL ϩ SV 3 , with 8 mm added for women until 30 April 1996 and a 6-mm gender adjustment thereafter) with a partition value of 2440 mm ϫ msec; and 2) modified Sokolow Lyon precordial voltage criteria (SV 1 ϩ RV 5-6 Ͼ38 mm). Patients with history of a myocardial infarction or stroke within the past 6 months or requiring treatment with a ␤-blocker, an angiotensin converting enzyme inhibitor or an angiotensin II blocker were excluded from the study.
Echocardiographic Study
Approximately 10% of the total of 9194 LIFE participants were recruited into the echocardiographic study. 21 After screening and qualification, study patients entered a 2-to 3-week placebo run-in period after which they underwent baseline evaluation that included complete echocardiographic assessment. Seated BP measured at the baseline clinic visit are used for all purposes in this report, except evaluation of end-systolic stress and total peripheral resistance for which pressures measured at the time of echocardiography were used. Patients were classified as having ISH (systolic BP Ն140 mm Hg and diastolic BP Ͻ90 mm Hg), isolated diastolic hypertension (systolic BP Ͻ140 mm Hg and diastolic Ͼ90 mm Hg) or CSDH (systolic BP Ͼ140 mm Hg and diastolic BP Ͼ90 mm Hg). This classification is consistent with the recently published World Health Organization-International Society of Hypertension guidelines. 22 Only 13 LIFE echocardiography study participants had isolated diastolic hypertension; they were excluded from the present study because of the small size of this group. Centers for the present LIFE study were chosen on the basis of established expertise in quantitative echocardiography. To standardize echocardiogram performance, sonographers for each center underwent local pretraining using written materials including a procedure manual adapted from that used in previous multicenter studies. [21] [22] [23] Subsequently, sonographers attended 1-day training courses given at the Echocardiography Reading Center at the New York Hospital-Cornell Medical Center in New York or at the Ulleval Hospital in Oslo, Norway. Imaging and Doppler parameters were measured by clinical center sonographers on each study using a standardized worksheet, and these worksheets and telephone calls were used to communicate from the Reading Center to examining sonographers. Methods of echocardiogram acquisition, measurements of anatomic variables, indexes of systolic and diastolic LV function, and methods of calculation of derived variables have been previously described in detail. [22] [23] [24] [25] In a separate population of 183 hypertensive patients in which two echocardiograms performed a mean of 45 days apart were interpreted at the Reading Center, there was excellent reliability of measurements of LV mass (intraclass correlation coefficient [RHO] ϭ 0.93) and of primary measurements of LV wall thickness and chamber diameter (RHO ϭ 0.83 to 0.87, all P Ͻ .001). 26 Reproducibility was also good (RHO ϭ 0.56 to 0.71, all P Ͻ .001) for LV functional measurements including LV fractional shortening, mid-wall shortening, end-systolic stress, and stress-corrected mid-wall shortening. 26 Stroke volume was measured by an invasively validated Doppler echocardiographic method 27 : stroke volume was calculated as the difference between end-diastolic and endsystolic LV volumes. Left ventricular chamber volumes at end-diastole and end-systole were estimated from the respective LV internal dimensions in centimeters by the formula of Teichholz et al: LV volume ϭ 7/(left ventricular internal diastolic diameter [LVID] ϩ 2.4) ϫ LVID 3 .
17,27
This formula was developed by comparison with angiographic LV volumes and its ability to measure chamber volumes was subsequently validated by comparison with invasive or Doppler echocardiographic reference standards. Stroke volume was used to calculate cardiac output, total peripheral resistance, and the pulse pressure/stroke volume ratio as an indirect estimate of global arterial stiffness.
Statistical Analyses
Data are expressed as mean Ϯ standard deviation. Relations between variables were assessed by Pearson or Spearman correlation coefficients. Multivariate analyses to determine the independent correlates of LV mass and relative wall thickness were performed using a stepwise forward procedure with assessment of collinearity diagnostics. Differences in clinical variables between groups of LIFE participants with ISH or CSDH were assessed by one-way analysis of variance followed by the Scheffé's test. Differences between groups in echocardiographic variables were analyzed taking age, gender, and heart rate into account by general linear model followed, when relevant, by linear regression analysis using as indicator variables for ISH, gender, and age. Categoric variables were compared by 2 statistics with the Bonferroni correction for multiple comparisons. Using predefined criteria that had been chosen based on the ability to predict adverse prognosis, 9 LV hypertrophy was considered present if LV mass/body surface area was Ͼ104 g/m 2 in women and Ͼ116 g/m 2 in men. Hypertrophy was considered concentric if LV relative wall thickness (posterior wall thickness/LV internal dimension) exceeded 0.43 and eccentric if relative wall thickness was in the normal range; patients with normal LV mass were considered to have normal LV geometry if relative wall thickness was Ͻ0.43 or to have concentric remodeling if relative wall thickness was increased. The potential impact on LV geometry of differences among these groups in clinical variables was controlled for by analysis of covariance.
Results
Patient Characteristics
Of the 951 echocardiographic study participants eligible for the present study, 143 had isolated systolic hypertension (ISH SBP Ն140 mm Hg and DBP Ͻ90 mm Hg), and 808 patients had combined hypertension (CSDH, SBP Ն140 mm Hg and DBP Ն90 mm Hg). The proportion of women was slightly higher in the ISH group than in the CSDH group (Table 1) . As expected, patients with ISH were older than patients with CSDH, due at least in part to an expected positive relation (r ϭ 0.35, P Ͻ .001) between age and pulse pressure among LIFE patients. The lower height in the ISH group persisted (P ϭ .002) after adjustment for gender and age, whereas body weight and BMI were similar between groups with or without adjustment for covariates. By definition, patients with ISH had much lower DBP than patients with CSDH. However, SBP in ISH patients was similar to CSDH patients. Heart rate was slower in ISH than in CSDH patients.
Left Ventricular Geometry
As shown in Table 2 , there was no difference in any anatomic LV measure between patients with ISH and patients with CSDH. LV wall thicknesses and mass indexed to body surface area (BSA) or height (2.7) were virtually identical in the two groups, whereas trends toward lower LV chamber size and LV mass in absolute terms in ISH patients did not reach statistical significance (P ϭ .07 and .06). The distribution of geometric patterns-concentric remodeling, eccentric or concentric LV hypertrophy-were also similar between the two groups.
Left Ventricular Systolic Function
The mean levels of endocardial fractional shortening, cardiac output, mid-wall fractional shortening in absolute terms or after stress correction were similar between the two groups (Table 3) . Total peripheral resistance index was significantly lower in patients with ISH compared to patients with CSDH. The pulse pressure/stroke volume ratio-an index of arterial stiffness-was significantly higher in ISH patients, compared to patients with CSDH, independently of age, gender, and heart rate, and remained so (P ϭ .004) when body surface area was also considered.
Diastolic Filling Parameters
Measured or calculated variables of LV diastolic filling were generally similar among the two groups ( Table 4 ). The atrial filling fraction measured at the tip of the mitral valve leaflets and at the mitral annulus was significantly lower in patients with ISH compared to the CSDH group, with adjustment for effects of age, gender, and heart rate. The isovolumic relaxation time was also shorter after adjustment for covariates in patients with ISH than with CSDH.
Relations of LV Mass to ISH and Associated Features
Continuous relations between LV clinical mass and features found to be associated with ISH in Table 1 were first examined by univariate correlation analysis and further by multiple linear regression analysis. Left ventricular mass correlated with older age (r ϭ 0.07, P ϭ .045), height (r ϭ 0.42, P Ͻ .001), body mass index (BMI) (r ϭ 0.21, P Ͻ .001), stress-corrected midwall fractional shortening (MWS) (r ϭ 0.30, P ϭ .001), and stroke volume (r ϭ 0.25, P Ͻ .001). Multiple linear regression analysis confirmed the independent contributions of age, height, BMI, stresscorrected MWS, stroke volume, male gender, and mean BP to LV mass (all P Ͻ.001; Table 5 ). Taken together these variables appeared to explain 40% of interpatient variability of LV mass. An additional regression analysis, which is an indicator variable, was added to compare patients with ISH to those with CSDH, revealed no independent impact of ISH on LV mass after mean BP and the other stimuli to LV hypertrophy were taken into account. In alternative models, SBP (P Ͻ .009) and CSDH as opposed ISH (P ϭ .017) was associated with LV mass independently of the other covariates, whereas when DBP was considered, it was positively related to LV mass (P ϭ .003), whereas the indicator variable for ISH was not (P Ͼ .15). When relative wall thickness was considered as the dependent variable, ISH was associated with higher values (P ϭ .001) independently of mean pressure, height, and stress (P ϭ .030) corrected mid-wall shortening (all P Ͻ .001) as well as lower BMI.
Discussion
The present study is the largest echocardiographic study that compared patients with ISH to patients with CSDH. This study also performed comprehensive assessment of LV structure, diastolic and systolic LV function (including mid-wall mechanics), and hemodynamic measurements (cardiac output, total peripheral resistance (TPR), and an indirect measure of arterial stiffness) in patients with ISH and combined hypertension from the same population. The population in the present study (as in the general LIFE study) is also different from previous reports. It was selected on the basis of elevation of either SBP or DBP or both and the presence of electrocardiographic criteria for LVH. As a result more than 81% of patients in this study had abnormal LV geometry. Even those patients with "normal" LV structure had significantly higher LV mass FS ϭ fractional shortening; MWS ϭ midwall fractional shortening; BSA ϭ body surface area; TPR ϭ total peripheral resistance; other abbreviations as in Tables 1 and 2 . IVSD ϭ intraventricular septum in diastole; PWTD ϭ posterior wall thickness in diastole; LVIDD ϭ left ventricular internal dimension in diastole; RWTD ϭ relative wall thickness in diastole; other abbreviations as in Table 1 .
and indexed mass compared to normotensive controls studied by the Echocardiography Reading Center (data not shown).
The present study clearly demonstrates that, compared to patients with combined (systolic/diastolic) hypertension whose mean arterial pressure was an average 12 mm Hg higher, patients with ISH have similar changes in LV geometry and function. LV wall thickness, dimension, and LV mass indexed for either BSA or height (2.7) were virtually identical in ISH and systolic/diastolic hypertensive groups despite substantial and significant differences of 12 mm Hg in mean and 18 mm Hg in DBP. These findings strongly suggest a greater role for systolic than mean and especially, diastolic BP in the development of LV target organ abnormalities.
The majority of patients, both in the ISH (77%) and CSDH (82%) (P ϭ not significant) groups, had abnormal LV geometric patterns. There was no difference in the distribution of concentric remodeling, eccentric or concentric LVH patterns between the two groups, suggesting similar pathologic effects of these two patterns of hypertension despite a substantial between-group difference in mean and diastolic arterial pressure.
Several echocardiographic studies have assessed LV structural changes in patients with ISH, [15] [16] [17] [18] [19] but only one study had a comparison group with CSDH. 18 This study included previously untreated patients with ISH and compared them to normotensive controls and previously untreated patients with CSDH. They too found similar changes in LV mass index, wall thickness, and geometric patterns in ISH and CSDH patients. In that study, however, the predominant geometric pattern was LV concentric remodeling, whereas in our study there was a definite increase in LV mass in the majority of patients. The difference in the prevalence of geometric patterns between the two studies can be easily explained on the basis of the study populations. Patients in our study were selected on the basis of established LVH (by electrocardiogram), whereas in the study by Heesen et al 18 they were drawn from a population survey. However, the lack of substantial LV geometric differences between ISH and non-ISH hypertensives in the LIFE study resembles the minimal differences of 5 g of LV mass and 0.01 cm of posterior wall thickness between 668 participants with ISH and 803 other hypertensives in the population-based Strong Heart Study (RB Devereux, unpublished data). Other studies also found increased LV mass in patients with ISH compared to normotensive controls. [15] [16] [17] ). In the largest of these studies, the Cardiovascular Health Study, 16 ISH was strongly associated with LV mass increase, but no comparison was provided to patients with CSDH.
In the present study total peripheral resistance was significantly lower in patients with ISH than in patients with CSDH. A measure of systemic arterial stiffness (pulse pressure/stroke volume index ratio) was significantly higher in patients with ISH than in patients with CSDH, a difference that remained significant after adjustment for age, gender, heart rate, and BSA.
These data are consistent with the findings of other studies. Stiffness of the aorta and major conducting vessels is crucial in the development of ISH. 28 -30 Two of the main factors that contribute to the increase in SBP are the rapid increase during myocardial contraction and the increase in pulse wave velocity. Earlier reflection of pressure waves Abbreviations as in Tables 1 and 3 .
Variables not significant: Diastolic blood pressure, isolated systolic hypertension.
from the periphery leads to summation of the reflected wave with the initial systolic pressure wave to produce a later and higher systolic peak and a relative reduction in diastolic pressure. In many cases of ISH there is also an increased TPR with an elevation in mean arterial pressure. 28 Using impedance cardiography Galarzia et al 31 found that, compared to age-matched normal controls, arterial compliance was 48% lower in patients with ISH and 30% lower in patients with CSDH. In summary, data from the present study indicate that ISH has a similar impact on LV structure as CSDH despite a lower mean and DBP in the former group, thereby adding to the mounting evidence that SBP plays the primary role in determining hypertensive target organ damage. Additional analysis identified associations, independent of covariates, between ISH with higher LV relative wall thickness and arterial stiffness, both predictors of an adverse prognosis, 13, 32 but also with small, potentially favorable differences in measure of LV diastolic filling, isovolumic relaxation time, and atrial filling fraction. Further analysis to relate ISH and its associated abnormalities to prognosis will be needed at the end of the LIFE trial.
